SCHEMBL17952999

SCHEMBL17952999

CC1=Cc2c(-c3cccc4ccccc34)cccc2C1C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.37
CYP2A6 P11509 1/20 0.37
CA12 O43570 2/20 0.36
CA1 P00915 2/20 0.36
CA2 P00918 2/20 0.36
CA9 Q16790 2/20 0.36
DHFR P00374 1/20 0.36
PTPN1 P18031 1/20 0.35
KDM4E B2RXH2 4/20 0.35
HPGD P15428 2/20 0.35
TDP2 O95551 1/20 0.35
MAPT P10636 1/20 0.35
ALOX12 P18054 1/20 0.35
MAPK1 P28482 1/20 0.35
CASP3 P42574 1/20 0.35
HTT P42858 1/20 0.35
GALK1 P51570 1/20 0.35
BLM P54132 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
SENP8 Q96LD8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5860453 0.84 ALDH1A1 (0.37) ALDH1A1CYP2A6CA12CA1CA2
SCHEMBL30229819 0.84 ALDH1A1 (0.37) ALDH1A1CYP2A6CA12CA1CA2
SCHEMBL28529430 0.83 ALDH1A1 (0.36) ALDH1A1CYP2A6CA12CA1CA2
SCHEMBL28012310 0.83 ALDH1A1 (0.36) ALDH1A1CYP2A6CA12CA1CA2
SCHEMBL7252936 0.83 ALDH1A1 (0.36) ALDH1A1CYP2A6CA12CA1CA2
SCHEMBL7996888 0.83 ALDH1A1 (0.36) ALDH1A1CYP2A6CA12CA1CA2
SCHEMBL6329142 0.81 ALDH1A1 (0.35) ALDH1A1CYP2A6CA12CA1CA2
SCHEMBL7039658 0.81 ALDH1A1 (0.36) ALDH1A1CYP2A6CA12CA1CA2
Hydrochloric Acid SCHEMBL4068167 0.81 ALDH1A1 (0.35) ALDH1A1CYP2A6CA12CA1CA2
Hydrochloric Acid SCHEMBL4094244 0.81 ALDH1A1 (0.35) ALDH1A1CYP2A6CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160215004-A1 A NOVEL LIGAND COMPOUND, A PREPARATION METHOD THEREOF, A TRANSITION METAL COMPOUND, AND A PREPARATION METHOD THEREOF LG CHEM, LTD. (KR) 2016-07-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160215004-A1 A NOVEL LIGAND COMPOUND, A PREPARATION METHOD THEREOF, A TRANSITION METAL COMPOUND, AND A PREPARATION METHOD THEREOF CD40LG, OSTC, TNFSF10 ALDH1A1 2895/4885CYP2A6 1587/4885CA12 2676/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.